Since DDC and ACE2 expression is regulated by hypoxia [14, 17–20, 22] and the HIF-target immune-modulatory gene EPO [21], we concurrently examined the expression profile of EPO in COVID-19 patients compared to the non-infected individuals. The gene discussed is ACE2; the disease is COVID-19.